Keyphrases
Breast Cancer Cell Lines
100%
Mammosphere
100%
Cancer Stem Cells
100%
Tyrosine Kinase Inhibitor
100%
Combined Treatment
100%
Topoisomerase
100%
Topoi
50%
Topoisomerase Inhibitors
37%
In Cancer
25%
Etoposide
25%
Topo II
25%
Cell Viability
12%
Tumor
12%
Cancer Treatment
12%
Biological Behavior
12%
Therapeutic Approaches
12%
New Therapies
12%
Flow Cytometry
12%
Advanced Disease
12%
Reduced Sensitivity
12%
Nuclear Proteins
12%
Cell Population
12%
Tumor Development
12%
Protein Level
12%
Activity Level
12%
CD44+
12%
Immunostaining
12%
Treatment Therapy
12%
Breast Carcinoma
12%
Essential Enzymes
12%
Stem Cell Population
12%
Small Populations
12%
MCF-7 Cells
12%
Tumor Stage
12%
Non-adherent
12%
Erlotinib
12%
Enhanced Resistance
12%
Efficient Strategy
12%
PARP Inhibitor (PARPi)
12%
Anticancer Effect
12%
Human Prostate Cancer Cells
12%
Protein Extract
12%
Adherent Cells
12%
Current Therapeutics
12%
CD24
12%
Gefitinib
12%
Anticancer Target
12%
Neutral Red Assay
12%
4 T1
12%
Antitopoisomerase
12%
Camptothecin
12%
Microscopic Imaging
12%
Mammary Carcinoma Cells
12%
DNA Topoisomerase
12%
Topoisomerase Activity
12%
Fluorescent Microscopy
12%
Rare Cells
12%
PARP-1 Inhibitor
12%
Sphere-like
12%
3-aminobenzamide
12%
Cell Progression
12%
MCF7 Breast Cancer Cells
12%
Specific Culture Media
12%
Medicine and Dentistry
Cancer Stem Cell
100%
Breast Cancer Cell Line
100%
Topoisomerase
100%
Tyrosine-Kinase Inhibitor
100%
Cancer Cell
25%
Neoplasm
25%
Malignant Neoplasm
25%
Cell Population
25%
Etoposide
25%
Breast Carcinoma
25%
Poly ADP Ribose Polymerase
25%
Disease
12%
Flow Cytometry
12%
Cell Viability
12%
Breast Cancer
12%
Prostate Cancer
12%
Carcinoma Cell
12%
Immunohistochemistry
12%
Cell Line
12%
Cancer Therapy
12%
Fluorescence Microscopy
12%
Enzymes
12%
Adherent Cell
12%
DNA Topoisomerase (ATP Hydrolysing)
12%
Gefitinib
12%
Nuclear Protein
12%
Topoisomerase Inhibitor
12%
Neutral Red
12%
3 Aminobenzamide
12%
Erlotinib
12%
Camptothecin
12%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Cancer Stem Cell
100%
Tyrosine Kinase Inhibitor
100%
Topoisomerase
100%
Enzyme
37%
Poly ADP Ribose Polymerase
25%
Mouse
12%
Cell Viability
12%
Nuclear Protein
12%
Flow Cytometry
12%
Immunostaining
12%
DNA Topoisomerase
12%
Topoisomerase
12%
Erlotinib
12%
DNA Gyrase
12%
CD44
12%
CD24
12%
Gefitinib
12%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Breast Cancer
100%
Protein Tyrosine Kinase Inhibitor
100%
Neoplasm
18%
Breast Carcinoma
18%
Etoposide
18%
Mouse
9%
Disease
9%
Flow Cytometry
9%
Prostate Cancer
9%
Cell Viability
9%
Erlotinib
9%
Enzymes
9%
DNA Topoisomerase (ATP Hydrolysing)
9%
Nuclear Protein
9%
Gefitinib
9%
Neutral Red
9%
DNA Topoisomerase Inhibitor
9%
Camptothecin
9%
3 Aminobenzamide
9%